Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Return on Capital Employed (2023 - 2025)

Bioregenx has reported Return on Capital Employed over the past 3 years, most recently at 37.96% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 46732.0% year-over-year to 37.96%; the TTM value through Dec 2025 reached 37.96%, up 46732.0%, while the annual FY2025 figure was 34.49%, 73818.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 37.96% at Bioregenx, down from 671.26% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 1771.56% in Q3 2023 and troughed at 1841.56% in Q2 2023.
  • A 3-year average of 52.27% and a median of 2.47% in 2024 define the central range for Return on Capital Employed.
  • On a YoY basis, Return on Capital Employed climbed as much as 179573bps in 2024 and fell as far as -180458bps in 2024.
  • Year by year, Return on Capital Employed stood at 145.84% in 2023, then plummeted by -394bps to 429.35% in 2024, then soared by 109bps to 37.96% in 2025.
  • Business Quant data shows Return on Capital Employed for BRGX at 37.96% in Q4 2025, 671.26% in Q3 2025, and 609.34% in Q2 2025.